newsfilter
← Latest News
Business Wire·

Rallybio Corporation and Candid Therapeutics Announce Merger Agreement

Combined company to operate as Candid Therapeutics, advancing a leading portfolio of T-cell engager therapeutics for autoimmune diseases Concurrent significantly oversubscribed and upsized financing of over $505